Literature DB >> 20299869

Overview of chronic kidney disease in children.

Michel Baum.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20299869      PMCID： PMC2880183          DOI： 10.1097/MOP.0b013e32833695cb

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN： 1040-8703            Impact factor:   2.856


× No keyword cloud information.
  10 in total

Review 1.  Prenatal programming of hypertension: lessons from experimental models.

Authors:  V Matti Vehaskari; Lori L Woods
Journal:  J Am Soc Nephrol       Date:  2005-07-27       Impact factor: 10.121

Review 2.  The hemodynamic basis of progressive renal disease.

Authors:  B R Dunn; S Anderson; B M Brenner
Journal:  Semin Nephrol       Date:  1986-06       Impact factor: 5.299

Review 3.  The role of intraglomerular pressure in the initiation and progression of renal disease.

Authors:  S Anderson; B M Brenner
Journal:  J Hypertens Suppl       Date:  1986-12

Review 4.  Pediatric renal transplantation: an overview and update.

Authors:  Ashima Gulati; Minnie M Sarwal
Journal:  Curr Opin Pediatr       Date:  2010-04       Impact factor: 2.856

Review 5.  Prenatal programming of kidney disease.

Authors:  V Matti Vehaskari
Journal:  Curr Opin Pediatr       Date:  2010-04       Impact factor: 2.856

Review 6.  Risk factors for progression of chronic kidney disease.

Authors:  Amy Staples; Craig Wong
Journal:  Curr Opin Pediatr       Date:  2010-04       Impact factor: 2.856

Review 7.  Pediatric renal supportive therapies: the changing face of pediatric renal replacement approaches.

Authors:  Ari Auron; Patrick D Brophy
Journal:  Curr Opin Pediatr       Date:  2010-04       Impact factor: 2.856

8.  Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.

Authors:  S Anderson; T W Meyer; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

Review 9.  Can we slow the progression of chronic kidney disease?

Authors:  Elke Wühl; Franz Schaefer
Journal:  Curr Opin Pediatr       Date:  2010-04       Impact factor: 2.856

Review 10.  Role of the kidney in the prenatal and early postnatal programming of hypertension.

Authors:  Michel Baum
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-30
  10 in total
  11 in total

1.  A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary program.

Authors:  Debora C Cerqueira; Cristina M Soares; Vanessa R Silva; Juliana O Magalhães; Isabella P Barcelos; Mariana G Duarte; Sergio V Pinheiro; Enrico A Colosimo; Ana Cristina Simões e Silva; Eduardo A Oliveira
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

2.  Behavioral disorders and low quality of life in children and adolescents with chronic kidney disease.

Authors:  Renata C Marciano; Cristina M Bouissou Soares; José Silvério S Diniz; Eleonora M Lima; Jose Maria P Silva; Monica R Canhestro; Andrea Gazzinelli; Carla Cristina D Melo; Cristiane S Dias; Ana Cristina Simões e Silva; Humberto Correa; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2010-11-26       Impact factor: 3.714

3.  Baseline characteristics of participants in the NAVKIDS2 trial: a patient navigator program in children with chronic kidney disease.

Authors:  Chandana Guha; Rabia Khalid; Anita van Zwieten; Anna Francis; Carmel M Hawley; Allison Jauré; Armando Teixeira-Pinto; Alistair R Mallard; Amelie Bernier-Jean; David W Johnson; Deirdre Hahn; Donna Reidlinger; Elaine M Pascoe; Elizabeth G Ryan; Fiona Mackie; Hugh J McCarthy; Jonathan C Craig; Julie Varghese; Charani Kiriwandeniya; Kirsten Howard; Nicholas G Larkins; Luke Macauley; Amanda Walker; Martin Howell; Michelle Irving; Patrina H Y Caldwell; Reginald Woodleigh; Shilpanjali Jesudason; Simon A Carter; Sean E Kennedy; Stephen I Alexander; Steven McTaggart; Germaine Wong
Journal:  Pediatr Nephrol       Date:  2022-10-20       Impact factor: 3.651

4.  Quality of life in children with end-stage renal disease based on a PedsQL ESRD module.

Authors:  Ki-Soo Park; Young Ju Hwang; Min Hyun Cho; Cheol Woo Ko; Il Soo Ha; Hee Gyung Kang; Hae Il Cheong; Young Seo Park; Yoon Jung Lee; Joo Hoon Lee; Hee Yeon Cho
Journal:  Pediatr Nephrol       Date:  2012-07-26       Impact factor: 3.714

5.  Validity and reliability of the Korean version of the pediatric quality of life ESRD module.

Authors:  Ki-Soo Park; Min Hyun Cho; Il Soo Ha; Hee Gyung Kang; Hae Il Cheong; Young Seo Park; Yoon Jung Lee; Joo Hoon Lee; Hee Yeon Cho
Journal:  Health Qual Life Outcomes       Date:  2012-06-06       Impact factor: 3.186

Review 6.  Clinical approach to quality of life in children with end-stage renal disease.

Authors:  Min Hyun Cho
Journal:  Korean J Pediatr       Date:  2013-08-27

7.  Anthropometric and biochemical profile of children and adolescents with chronic kidney disease in a predialysis pediatric interdisciplinary program.

Authors:  Vanessa R Silva; Cristina B Soares; Juliana O Magalhães; Isabella Peixoto de Barcelos; Debora C Cerqueira; Ana Cristina Simões e Silva; Eduardo A Oliveira
Journal:  ScientificWorldJournal       Date:  2015-01-13

8.  Chronic kidney disease in children.

Authors:  Francesca Becherucci; Rosa Maria Roperto; Marco Materassi; Paola Romagnani
Journal:  Clin Kidney J       Date:  2016-06-05

9.  A Biallelic Frameshift Mutation in Nephronectin Causes Bilateral Renal Agenesis in Humans.

Authors:  Lei Dai; Jingzhi Li; Liangqun Xie; Weinan Wang; Yang Lu; Mingkun Xie; Jingrui Huang; Kuifang Shen; Hui Yang; Chenlin Pei; Yanhua Zhao; Weishe Zhang
Journal:  J Am Soc Nephrol       Date:  2021-05-28       Impact factor: 14.978

10.  Serially assessed bisphenol A and phthalate exposure and association with kidney function in children with chronic kidney disease in the US and Canada: A longitudinal cohort study.

Authors:  Melanie H Jacobson; Yinxiang Wu; Mengling Liu; Teresa M Attina; Mrudula Naidu; Rajendiran Karthikraj; Kurunthachalam Kannan; Bradley A Warady; Susan Furth; Suzanne Vento; Howard Trachtman; Leonardo Trasande
Journal:  PLoS Med       Date:  2020-10-14       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.